British Journal of Urology

Cover image for British Journal of Urology

September 1996

Volume 78, Issue 3

Pages 325–463

Currently known as: BJU International

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. Phytotherapy for the prostate (pages 325–336)

      A.C. Buck

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00104.x

    2. The relevance of p53 mutation in urological malignancies: possible clinical implications for bladder cancer (pages 337–344)

      A.M.E. Nouri, F. Darakhshan, H. Cannell, A.M.I. Paris and R.T.D. Oliver

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00085.x

    3. Clinical, radiological and histological features of adrenal myelolipoma: review and experience with a further eight cases (pages 345–350)

      M.M. El-Mekresh, M. Abdel-Gawad, T. El-Diasty, M. El-Baz and M.A. Ghoneim

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00081.x

    4. Incidentally detected renal cell carcinoma: pathological features, survival trends and implications for treatment (pages 351–353)

      J.P. Sweeney, J.A. Thornhill, R. Grainger, T.E.D. McDermott and M.R. Butler

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00140.x

    5. Wegener's granulomatosis involving the urogenital tract (pages 354–357)

      A. Davenport, S.E. Downey, S. Goel and A.G. Maciver

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00166.x

    6. Expression of multidrug resistance-related genes (mdrl, MRP, GST-πand DNA topoisomerase II) in urothelial cancers (pages 361–368)

      W.-J. Kim, Y. Kakehi, W.-J. Wu, M. Fukumoto and O. Yoshida

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00099.x

    7. The management of superficial bladder cancer: an interactive seminar (pages 372–378)

      J.P. McFarlane, B.W. Ellis and S.J. Harland

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00135.x

    8. The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14 772 patients (pages 379–384)

      L. Wilton, G. Pearce, E. Edet, S. Freemantle, M.D.B. Stephens and R.D. Mann

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00091.x

    9. Improved reliability of uroflowmetry investigations: results of a portable home-based uroflowmetry study (pages 385–390)

      J.J.M.C.H De La Rosette, W.P.J. Witjes, F.M.J. Debruyne, P.L. Kersten and H. Wijkstra

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00115.x

    10. The role of an advanced thermotherapy device in prostatic voiding dysfunction (pages 391–397)

      P. Javlé, M. Blair, M. Palmer, S.A. Jenkins and K.F. Parsons

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00137.x

    11. A comparative study of laser ablation and transurethral electroresection for benign prostatic hyperplasia : results of a 6-month follow-up (pages 398–400)

      F. Sengör, O. Köse, E. Yücebas, M. Beysel, K. Erdogan and F. Narter

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00168.x

    12. Free-to-total prostate-specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia (pages 409–413)

      J.M. Wolff, H. Borchers, P.J. Effert, F.K. Habib and G. Jakse

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00095.x

    13. Abnormal prostatic cells in ejaculates from men with prostatic cancer — a preliminary report (pages 414–418)

      R.A. Gardiner, M.L.T.H. Samaratunga, R.A. Gwynne, A. Clague, G.J. Seymour and M.F. Lavin

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00089.x

    14. The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer (pages 419–425)

      E. Rogers, T. Gürpinar, Ö. Dillioglugil, M.W. Kattan, J.R. Goad, P.T. Scardino and D.P. Griffith

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00117.x

    15. The proportional decrease in prostate specific antigen level best predicts the duration of survival after hormonal therapy in patients with metastatic carcinoma of the prostate (pages 426–431)

      C.P. Evans, V. Gajendran, A. Tewari, K. Aslam, R. Juster, S. Gange, A. Eason and P. Narayan

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00079.x

    16. A 3-year follow-up of patients with localized prostate cancer operated on with or without pre-treatment with the GnRH-agonist triptorelin (pages 432–436)

      M. Hellström, M. Häggman, K. Pedersen, C. Busch and S. Brändstedt

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.t01-1-00097.x

    17. Open versus closed epididymal sperm retrieval in men with secondarily obstructed vasal systems—a preliminary report (pages 437–439)

      G.N. Collins, J.D. Critchlow, M.W.M. Lau and S.R. Payne

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00133.x

    18. The influence of temperature on changes in pH, lactate and morphology during testicular ischaemia (pages 440–445)

      M. Kallerhoff, A.J. Gross, I.C. Bötefür, G. Zöller, W. Weidner, A.F. Holstein and R.-H. Ringert

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00138.x

    19. Genitourinary tract injuries in girls (pages 446–449)

      H. Okur, M. Küçükaydin, A. Kazez, C. Turan and A. Bozkurt

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00078.x

    20. Stone matrix clearance from the pelvicalyceal system using a bottle-brush (pages 460–461)

      M.I. Anjum and J.H. Palmer

      Version of Record online: 29 OCT 2003 | DOI: 10.1046/j.1464-410X.1996.00191.x

SEARCH

SEARCH BY CITATION